SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The rally toward fresh highs is drawing attention ahead of the expected Q3 report, with traders weighing BRIUMVIs growth against unconfirmed buyout speculation and possible short-covering. Some see the move as a bet on earnings and the companys commercial prospects rather than an acquisition; no deal has been confirmed.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 AML trial reaching its prespecified 80th death event has triggered final analysis, with topline results expected this quarter. Traders are divided over whether GPS improved survival: bullish holders see the pending readout as a major catalyst, while bears question the efficacy case, and the share-price decline has intensified debate about selling pressure and alleged short activity.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal suspension have fueled Bitcoin selling and concerns about crypto exchange security. Traders disagree over whether the incident signals broader risk or is isolated to Binance, with some viewing the pullback as a buying opportunity and others warning of further downside.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is drawing attention amid a steep pullback from its highs, with traders citing semiconductor weakness, profit-taking and concerns that its valuation assumes years of strong AI-driven growth. Bulls point to potential data-center CPU demand and ARMs role in AI infrastructure, while bears question whether growth can justify the premium; the upcoming earnings report is a focus.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

A sharp selloff in silver and other precious metals is driving attention, with inflation concerns tied to higher energy prices and expectations of tighter interest rates weighing on the market. Traders are split between calling the decline a continuing routsometimes alleging manipulationand seeing oversold conditions as a possible buying opportunity.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KIM Q3 FFO Beats on Strong Leasing, Revenues Miss, 2026 Outlook Raised

Kimco Realty's Q3 2026 FFO rises 6.8% to 47 cents per share, beating estimates as leasing gains lift occupancy and prompt higher full-year guidance.

EXR's Q3 Core FFO Improves on Strong Same-Store NOI, Outlook Raised

Extra Space Storage's quarterly revenues beat estimates as same-store NOI rises 4.6%, prompting higher 2026 core FFO and NOI growth outlooks.

ESS Q3 FFO & Revenues Miss Estimates Amid Rising Property Expenses

Essex Property Trust's revenues miss estimates as costs outpace growth, but Northern California strength and revised 2026 core FFO guidance offer key highlights.

Alexandria's Q3 FFO & Revenues Beat Estimates on Strong Leasing

ARE's Q3 2026 FFO and revenues beat estimates on robust leasing activity, but declining rental rates and lower occupancy continue to weigh on performance.

WELL's Q3 FFO Beat Estimates on Strong SHO Portfolio Growth

Welltower's Q3 2026 FFO beat estimates as strong seniors housing growth, higher occupancy and expanding margins fuel a raised full-year earnings outlook.

AMT Q3 AFFO & Revenues Rise on Steady Demand, 2026 Outlook Raised

American Tower beats Q3 estimates as data center growth and global leasing demand boost revenues, prompting higher 2026 property revenue and AFFO outlooks.

Public Storage Q3 FFO Rises, Same-Store NOI Grows, 2026 Outlook Raised

PSA's Q3 results top estimates as same-store NOI returns to growth, acquisitions and ancillary operations boost results, and 2026 core FFO guidance is increased.

This CME Group Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Analysts upgraded Ionis, CME Group, DigitalOcean, Prologis and Zions Bancorporation, issuing new or revised price targets.read more...

Crown Castle's Q3 AFFO Beats Estimates on Lower Expenses

CCI's Q3 2026 AFFO beat estimates on lower interest expenses, despite declining revenues, while management raised its full-year AFFO and EBITDA outlook.

Futures Slip As Korean Data Center IPO Faceplant Revives Tech Rout, French Spread Blows Out

Futures Slip As Korean Data Center IPO Faceplant Revives Tech Rout, French Spread Blows Out

 US futures are lower, led by the Nasdaq, as Monday's AI relief bounce fizzled overnight after South Korean data-center firm Elice cratered more than 30% in its trading debut, reviving doubts...

• Reported GAAP EPS of $0.86 up 4.88% YoY
• Reported revenue of $2.39B up 7.84% YoY
• Prologis lowered its 2026 net earnings guidance to $4.05 to $4.15 per diluted share; Core FFO guidance is $6.25 to $6.29, and Cash Same Store NOI is 7.00% to 7.50%.

Prologis lowered 2026 net earnings and Strategic Capital revenue guidance; interest expense was $286.96M versus $258.27M in 3Q25; disclosed competition and SEGRO-combination completion risks.

Prologis reported 60M of leases and 38.0% net effective rent change; raised 2026 development-starts and stabilization ranges; and cited SEGRO approval as a milestone for European expansion.

Prologis, Inc. is a logistics real estate and digital infrastructure company. It combines a global real estate platform, strategic capital business and customer-focused logistics and energy solutions. It operates through the Real Estate and Strategic Capital segments. The Real Estate segment represents the ownership and development of operating properties and remains the largest component of the firm's revenue and earnings. The Strategic Capital segment focuses on the management of co-investment ventures and other unconsolidated entities. The company was founded by Hamid R. Moghadam in 1983 and is headquartered in San Francisco, CA.

Prologis Inc

Gen Z Tightens Wallets: US Holiday Spending To Fall For First Time Since Pandemic As Inflation And Tariffs Bite

Equity

Neutral Sentiment

U.S. holiday spending is projected to decline about 5% in 2024, the first notable drop since the pandemic, as Gen-Z shoppers cut back sharply due to inflation, tariffs, and rising living costs.More than eight in 10 consumers said they plan to reduce spending over the next six months, with Gen Z (ages 17–28) expecting to slash holiday outlays by 23%, while millennials, Gen X, and baby boomers anticipate spending the same or more, according to a PwC survey released Wednesday.The pullback comes as tariffs weigh more heavily on retailers and consumers.&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/de-minimis-ends-today-heres-whos-likely-to-win-and-lose-after-us-tariff-shift/chtThciRdNB">The U.S. ‘de minimis’ exemption</a>, which allowed tariff-free imports under $800 for nearly 90 years, ended Friday after U.S. President Donald Trump scrapped the rule.&nbsp;Chinese e-commerce platforms Shein, Temu, and Alibaba (BABA) had already been hit when the exemption for goods from mainland China and Hong Kong ended in May. By Aug. 29, the exemption ceased worldwide, forcing price hikes and squeezing cross-border sellers.Shein and Temu both raised prices ahead of the May deadline, with Shein’s sales sliding 23% year-on-year in June and Temu’s plunging 33%, before stabilizing post-rule change.Smaller importers and online sellers on eBay (EBAY) and Etsy (ETSY) are getting squeezed by the tariff changes, while giants like Amazon (AMZN), Walmart (WMT), Prologis (PLD) and DHL stand to benefit as more products shift to domestic supply chains.Walmart CEO Doug McMillon had already warned that costs were climbing week by week as the last of the tariff-free inventory disappeared. For shoppers, that means more attention on stretching dollars by picking products that deliver the best value,&nbsp; even as worries about jobs and inflation linger.Fresh signs of consumer anxiety came last week as the Conference Board’s confidence index fell to 97.4 in August from 98.7 in July, following a weak jobs report that underscored cracks in the labor market. Expectations for business conditions slipped, and the gauge of future income edged lower.“Notably, consumers’ appraisal of current job availability declined for the eighth consecutive month,” said Stephanie Guichard, senior economist at the Conference Board.On Stocktwits, sentiment around consumer staples ETF XLP swung sharply this year — from ‘extremely bullish’ in March to ‘extremely bearish’ by month-end, back to ‘bullish’ in August, and now bearish again. Meanwhile, sentiment toward consumer discretionary ETF XLY started the year ‘neutral,’ turned ‘bullish’ in April, softened mid-year, bounced in July, and now sits back at ‘neutral.’For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. holiday spending is projected to decline about 5% in 2024, the first notable drop since the pandemic, as Gen-Z shoppers cut back sharply due to inflation, tariffs, and rising living costs. (Photo credit: Getty Images)

PwC’s survey indicates that overall spending will decrease by about 5% from last year, with Gen Z reducing their holiday budgets by nearly a quarter, while older shoppers plan to maintain their current spending levels or increase it.

US Holiday Spending To Fall For First Time Since Pandemic As Inflation And Tariffs Bite

Amazon.com Inc

eBay Inc

Etsy Inc

Walmart Inc

Consumer Staples Select Sector SPDR Fund

Consumer Discretionary Select Sector SPDR Fund

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Futures

Fundamentals

Info

PLD Futures

PLD Single Stock Futures